Uyeki E M, Truitt G A, Bisel T U
Agents Actions. 1976 Nov;6(6):694-700. doi: 10.1007/BF02026090.
Incorporation of tritiated deoxythymidine (3HdT) into DNA was used to measure growth, in vitro, of P815 tumor cells admixed with spleen and peritoneal effector cells. At a high tumor cell density ((1x10(5) cells per dish), using anti-theta and anti-macrophage sera, T-cells and macrophages from the peritoneum of immunized mice could be identified as cells possessing anti-tumor activity. A nonspecific inhibition by normal effector cells, which occurred at the high tumor cell density, did not occur at a lower tumor cell density (1x10(4) cells per dish). Therefore, the effects of immunization and Freund's adjuvant treatment on the anti-tumor activity of effector cells were determined more accurately when normal cells were no longer inhibitory. Thus, experimental variables dealing with cellular density (cells/mm2 of the culture vessel surface) and effector:tumor cell ratios play an important role in the anti-proliferative capacity of effector cells.
利用氚标记的脱氧胸腺嘧啶核苷(3HdT)掺入DNA来测定与脾脏和腹膜效应细胞混合培养的P815肿瘤细胞的体外生长情况。在高肿瘤细胞密度(每培养皿1×10⁵个细胞)时,使用抗θ血清和抗巨噬细胞血清,可将免疫小鼠腹膜中的T细胞和巨噬细胞鉴定为具有抗肿瘤活性的细胞。正常效应细胞在高肿瘤细胞密度时出现的非特异性抑制作用,在较低肿瘤细胞密度(每培养皿1×10⁴个细胞)时并未出现。因此,当正常细胞不再具有抑制作用时,能更准确地确定免疫和弗氏佐剂处理对效应细胞抗肿瘤活性的影响。所以,涉及细胞密度(培养容器表面每平方毫米的细胞数)和效应细胞与肿瘤细胞比例的实验变量,在效应细胞的抗增殖能力中起着重要作用。